ketanserin and thromboxane b2

ketanserin has been researched along with thromboxane b2 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19907 (77.78)18.7374
1990's2 (22.22)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gambini, G; Rossi, S; Valori, C1
Hechtman, DH; Jageneau, A1
Finesso, M; Prosdocimi, M; Zatta, A1
David, JL; de Clerck, F; Janssen, PA2
McGoon, MD; Vanhoutte, PM1
Hechtman, HB; Huval, WV; Lelcuk, S; Shepro, D1
Cohen, RA; Shepherd, JT; Vanhoutte, PM1

Trials

2 trial(s) available for ketanserin and thromboxane b2

ArticleYear
Platelet function during long-term treatment with ketanserin of claudicating patients with peripheral atherosclerosis. A multi-center, double-blind, placebo-controlled trial. The PACK Trial Group.
    Thrombosis research, 1989, Jul-01, Volume: 55, Issue:1

    Topics: beta-Thromboglobulin; Calcium; Clinical Trials as Topic; Double-Blind Method; Humans; Intermittent Claudication; Ketanserin; Multicenter Studies as Topic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Serotonin; Thromboxane B2

1989
Inhibition of cold-induced vasoconstriction with ketanserin.
    Microvascular research, 1985, Volume: 30, Issue:1

    Topics: Adult; Cold Temperature; Hand; Humans; Ibuprofen; Ketanserin; Ketoconazole; Male; Middle Aged; Piperidines; Regional Blood Flow; Serotonin; Skin Temperature; Thromboxane B2; Vasoconstriction

1985

Other Studies

7 other study(ies) available for ketanserin and thromboxane b2

ArticleYear
Absence of effects of ketanserin on renal prostacyclin and thromboxane A2 in essential hypertension.
    European heart journal, 1991, Volume: 12, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Epoprostenol; Female; Humans; Hypertension; Ketanserin; Kidney; Male; Middle Aged; Renin-Angiotensin System; Thromboxane A2; Thromboxane B2

1991
Stenosis and vascular damage as a cause of thrombosis in the dog femoral artery.
    Naunyn-Schmiedeberg's archives of pharmacology, 1988, Volume: 338, Issue:4

    Topics: Angiography; Animals; Blood Pressure; Blood Vessels; Dogs; Femoral Artery; Heart Rate; Imidazoles; In Vitro Techniques; Ketanserin; Male; Regional Blood Flow; Thrombosis; Thromboxane B2; Thromboxane-A Synthase

1988
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
    Agents and actions, 1982, Volume: 12, Issue:3

    Topics: beta-Thromboglobulin; Blood Platelets; Blood Proteins; Humans; In Vitro Techniques; Ketanserin; Malondialdehyde; Piperidines; Platelet Aggregation; Serotonin; Serotonin Antagonists; Thromboxane B2

1982
Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine.
    The Journal of clinical investigation, 1984, Volume: 74, Issue:3

    Topics: Animals; Blood Platelets; Dogs; Epinephrine; In Vitro Techniques; Ketanserin; Muscle Contraction; Norepinephrine; Piperidines; Platelet Aggregation; Pulmonary Artery; Serotonin; Serotonin Antagonists; Thromboxane B2

1984
Role of serotonin in patients with acute respiratory failure.
    Annals of surgery, 1984, Volume: 200, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Adult; Aged; Blood Platelets; Blood Pressure; Cardiac Output; Female; Humans; Intubation, Intratracheal; Ketanserin; Male; Middle Aged; Piperidines; Platelet Count; Pulmonary Wedge Pressure; Respiratory Function Tests; Respiratory Insufficiency; Serotonin; Serotonin Antagonists; Thromboxane B2

1984
5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
    The American journal of physiology, 1983, Volume: 245, Issue:6

    Topics: Animals; Blood Platelets; Coronary Vessels; Dogs; In Vitro Techniques; Isometric Contraction; Ketanserin; Methysergide; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Piperidines; Serotonin; Serotonin Antagonists; Thromboxane B2

1983
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.
    Agents and actions, 1994, Volume: 43, Issue:3-4

    Topics: Adenosine Diphosphate; History, 20th Century; Humans; Ketanserin; Platelet Aggregation; Serotonin; Thromboxane B2

1994